Patient number
|
Age range at presentation
|
Age range at metastases
|
Tumor diameter (cm)
|
pT-stage
|
pN-stage
|
M-stage
|
Site of metastases
|
Tg at diagnosis of metastases
|
Survival
|
Disease-free interval
|
Survival from diagnosis of distant metastases
|
Cause of death
|
---|
1
|
85–89
|
85–89
|
7,5
|
3
|
0
|
1
|
L
|
7414
|
77
|
0
|
77
|
DDM
|
2
|
75–79
|
75–79
|
5
|
4b
|
0
|
1
|
L
|
4450
|
53
|
0
|
53
|
DOC
|
3
|
70–74
|
70–74
|
8
|
3
|
0
|
1
|
L
|
265
|
141
|
0
|
141
|
DDM
|
4
|
70–74
|
70–74
|
6
|
4a
|
0
|
1
|
B
|
183
|
13
|
0
|
13
|
DDM
|
5
|
65–69
|
65–69
|
8,5
|
3
|
0
|
1
|
L
|
16650
|
185
|
0
|
185
|
Alive
|
6
|
65–69
|
65–69
|
8
|
3
|
0
|
1
|
BL
|
4010
|
148
|
0
|
148
|
DDM
|
7
|
60–64
|
60–64
|
8
|
0
|
0
|
1
|
B
|
No data
|
153
|
0
|
153
|
DDM
|
8
|
60–64
|
60–64
|
4,5
|
3
|
1b
|
1
|
L
|
62600
|
131
|
0
|
131
|
DDM
|
9
|
60–64
|
60–64
|
2
|
2
|
0
|
1
|
B
|
69
|
1
|
0
|
1
|
LFU
|
10
|
60–64
|
60–64
|
6,5
|
3
|
0
|
1
|
L
|
1300
|
72
|
0
|
72
|
DDM
|
11
|
55–59
|
55–59
|
5
|
4b
|
1b
|
1
|
L
|
190
|
201
|
0
|
201
|
DDM
|
12
|
45–49
|
45–49
|
9
|
4b
|
0
|
1
|
L
|
5800
|
52
|
0
|
52
|
DDM
|
13
|
85–89
|
85–89
|
12
|
3
|
0
|
0
|
Mediastinum
|
277
|
52
|
38
|
14
|
DDM
|
14
|
75–79
|
75–79
|
3
|
2
|
0
|
0
|
B
|
47
|
126
|
34
|
92
|
Alive
|
15
|
75–79
|
85–89
|
8
|
3
|
0
|
0
|
L
|
696
|
144
|
84
|
60
|
DDM
|
16
|
70–74
|
70–74
|
2
|
4a
|
1a
|
0
|
Kidney
|
1432
|
318
|
180
|
138
|
DDM
|
17
|
70–74
|
75–79
|
8
|
3
|
0
|
0
|
L
|
1300
|
63
|
36
|
2
|
DDLTP
|
18
|
70–74
|
80–84
|
6,8
|
3
|
0
|
0
|
L
|
1000
|
132
|
96
|
36
|
Alive
|
19
|
70–74
|
70–74
|
5,5
|
4a
|
0
|
0
|
L
|
No data
|
26
|
3
|
23
|
DDM
|
20
|
65–69
|
65–69
|
3,6
|
3
|
0
|
0
|
L
|
0.1
|
46
|
43
|
3
|
Alive
|
21
|
65–69
|
70–74
|
7
|
4a
|
0
|
0
|
L
|
No data
|
63
|
53
|
10
|
DDM
|
22
|
65–69
|
65–69
|
9
|
3
|
0
|
0
|
BL
|
1100
|
145
|
52
|
93
|
DDM
|
23
|
60–64
|
65–69
|
18
|
4b
|
1b
|
0
|
L
|
416
|
100
|
20
|
53
|
DDM
|
24
|
60–64
|
70–74
|
3
|
2
|
0
|
0
|
L, liver
|
501
|
121
|
84
|
36
|
DDM
|
25
|
60–64
|
65–69
|
4,5
|
3
|
0
|
0
|
L
|
30773
|
97
|
49
|
48
|
Alive
|
26
|
60–64
|
70–74
|
7
|
3
|
0
|
0
|
L
|
196
|
138
|
113
|
27
|
Alive
|
27
|
60–64
|
60–64
|
6,5
|
3
|
1a
|
0
|
B
|
763
|
43
|
16
|
27
|
Alive
|
28
|
60–64
|
60–64
|
8
|
4a
|
0
|
0
|
Mediastinum
|
1800
|
145
|
44
|
101
|
DDLTP
|
29
|
50–54
|
55–59
|
13
|
4b
|
0
|
0
|
L
|
800
|
75
|
26
|
42
|
DDM
|
30
|
50–54
|
75–79
|
6
|
3
|
0
|
0
|
L
|
163
|
337
|
31
|
65
|
DDM
|
31
|
50–54
|
50–54
|
3
|
2
|
1b
|
0
|
L
|
Tg-antibodies
|
33
|
9
|
24
|
Alive
|
32
|
35–39
|
40–44
|
4
|
3
|
0
|
0
|
BL
|
108
|
286
|
60
|
226
|
Alive
|
- Legend: B bone, L lungs, DDM dead of distant metastases, DOC dead of other causes, LFU lost to follow-up, DDLTP dead of distant and locoregional tumor progression